ReviewHealth services insights2026
Chronic Kidney Disease Screening Practice Among High-Risk Patients During Follow-Up in Sub-Saharan Africa: A Systematic Review.
Review in Health services insights, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Screening for Chronic Kidney Disease (CKD) for high-risk patients is essential to provide early detection, management, and delayed progression. In Sub-Saharan Africa (SSA), CKD screening remains variable and inadequate. Therefore, the review question was: what is the current practice of screening for CKD in high-risk patients (hypertension and diabetes) attending chronic care follow-up visits in SSA? Methods: The systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 guidelines. The review included studies published from 2010 to August 2025. Inclusion criteria included screening practices or early detection of chronic kidney diseases among high-risk patients during routine care in SSA. The review followed the JBI Condition, Context, and Population (CoCoPop) protocol. Two independent reviewers screened, appraised, and extracted data using the standardized JBI SUMARI data extraction form. Narrative synthesis of the findings was carried out to understand CKD screening practice in SSA. Results: Out of 856 records identified, twelve studies from SSA focused on high-risk patients screened for CKD who met criteria and were included. Serum creatinine was the most common method used to screen CKD during routine follow-up of high-risk patients, followed by albuminuria and estimated glomerular filtration rate(eGFR). The prevalence of CKD screening during routine care varies from 8.4% to 38.5%. Older age, being a female, duration of diabetes and/or hypertension, and co-existence of hypertension and diabetes were identified as factors associated with CKD screening practice. Conclusion and recommendations: Routine follow-up of high-risk patients demonstrated that CKD screening was effective in early patient identification. Most of the included studies relied on one-time screening, which may not accurately represent the true prevalence; therefore, confirmatory CKD screening should be conducted. Finally, healthcare providers should prioritize older age, female gender, duration of the high-risk conditions, and concomitance of hypertension and diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.